AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
of Denmark
(2018
sales of 111.83 billion Danish Kroner [US$16.91 billion]
of which 84%
was Diabetes and obesity),
Lonza Group AG
of Switzerland
(5.54 billion Swiss Francs [US$5.50 billion]
of which 56%
was Pharma&Biotech), and
Merck KGaA
which is
based in Germany
(14.84 billion Euro [US$16.74 billion]
of which 42%
was Healthcare).
Sales Analysis.
During the year ended December of 2018, sales at
AstraZeneca PLC were £16.60 billion (US$21.67 billion).
This
is
a
decrease of 3.8%
versus 2017, when the company's sales were £17.25 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, AstraZeneca PLC had sales
of £16.41 billion.